CLBT241018C17500
- 0.35
- -0.20-36.36%
Cellebrite Newsroom
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating, Announces Target Price $23
Cellebrite Patents Its Remote Mobile Collection Capabilities for Businesses
Cellebrite DI Is Maintained at Buy by TD Cowen
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $23
Express News | Cellebrite DI Ltd : TD Cowen Raises Target Price to $23 From $20
Cellebrite DI Shareholders Approve All Proposals
Analysts Offer Insights on Technology Companies: Cellebrite DI (CLBT), Stratasys (SSYS) and Mitek Systems (MITK)
Cellebrite Enhances Investigative Analytics Solution With Amazon Web Services (AWS)
Cellebrite Shares Surge, Triggering Stock Issuance
Cellebrite DI Warrant Exercise Deadline Approaches
Cellebrite DI Announces Warrant Redemption Plan
Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS)
Why Cellebrite DI Ltd. (CLBT) Might Be Well Poised for a Surge
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Deutsche Bank Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $18
JPMorgan Adjusts Cellebrite DI Price Target to $17 From $15, Maintains Overweight Rating
Cellebrite DI Is Maintained at Overweight by JP Morgan
Express News | Cellebrite DI Shares Are Trading Higher After Multiple Firms Raised Their Respective Price Targets on the Stock
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Earnings Call: Cellebrite Reports Robust Q2 Growth With ARR up 26%